CXCR1: A Cancer Stem Cell Marker and Therapeutic Target in Solid Tumors

Therapy resistance is a significant concern while treating malignant disease. Accumulating evidence suggests that a subset of cancer cells potentiates tumor survival, therapy resistance, and relapse. Several different pathways regulate these purported cancer stem cells (CSCs). Evidence shows that th...

Full description

Bibliographic Details
Published in:	Biomedicines
Main Authors:	Caitlin Molczyk, Rakesh K. Singh
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Subjects:	chemokines cancer stem cell CXC receptors
Online Access:	https://www.mdpi.com/2227-9059/11/2/576

Similar Items

A Study of CD4, CCR3, CCR4, CCR5, CXCR3 Expression in Peripheral Blood Lymphocytes of Patients with Gastric Cancer
by: Alireza Andalib, et al.
Published: (2012-03-01)

Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic values
by: Lian-Tao Hu, et al.
Published: (2022-06-01)

Evolutionarily conserved mechanisms regulating stress-induced neutrophil redistribution in fish
by: Katarzyna Klak, et al.
Published: (2024-03-01)

CXCR Family and Hematologic Malignancies in the Bone Marrow Microenvironment
by: Yanquan Liu, et al.
Published: (2025-05-01)

Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy
by: Zhi-Jian Han, et al.
Published: (2021-12-01)

Circulating CXCR5+ natural killer cells are expanded in patients with myasthenia gravis
by: Meng‐Ru Ge, et al.
Published: (2023-01-01)

Fluorinated PEG-PEI Coated Magnetic Nanoparticles for siRNA Delivery and CXCR4 Knockdown
by: Yixiang Cao, et al.
Published: (2022-05-01)

Construction of CXCR4 Receptor-Targeted CuFeSe2 Nano Theranostic Platform and Its Application in MR/CT Dual Model Imaging and Photothermal Therapy
by: Li W, et al.
Published: (2024-09-01)

The Chemokines CXC, CC and C in the Pathogenesis of COVID-19 Disease and as Surrogates of Vaccine-Induced Innate and Adaptive Protective Responses
by: Mojgan Noroozi Karimabad, et al.
Published: (2022-08-01)

Histologic and inflammatory lamellar changes in horses with oligofructose-induced laminitis treated with a CXCR1/2 antagonist
by: Leonardo R. de Lima, et al.
Published: (2016-01-01)

Expression profile and prognostic value of CXCR family members in head and neck squamous cell carcinoma
by: Yiming Shen, et al.
Published: (2022-08-01)

CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
by: Xuezhi Zhou, et al.
Published: (2021-03-01)

The role of proinflammatory cytokines and CXC chemokines (CXCL1–CXCL16) in the progression of prostate cancer: insights on their therapeutic management
by: Amin Ullah, et al.
Published: (2024-05-01)

Analysis of therapeutic targets and prognostic biomarkers of CXC chemokines in cervical cancer microenvironment
by: Weina Kong, et al.
Published: (2021-07-01)

Effect of neferine on diabetic nephropathy by regulating SDF-1/CXCR4 signal pathway
by: WANG Ying, et al.
Published: (2024-02-01)

The Impact of Different Types of Physical Effort on the Expression of Selected Chemokine and Interleukin Receptor Genes in Peripheral Blood Cells
by: Robert Nowak, et al.
Published: (2023-04-01)

CC-chemokine ligand 18, CXC motif chemokine 13 and osteopontin as biomarkers of silicosis and asbestosis: a prospective observational study
by: Na Wu, et al.
Published: (2025-02-01)

Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: Insights from preclinical and clinical studies' outcomes
by: Amin Ullah, et al.
Published: (2024-06-01)

Comprehensive analysis of prognostic value and immune infiltration of CXC chemokines in pancreatic cancer
by: Yanhua Jing, et al.
Published: (2022-04-01)

Resveratrol and IL-6 Modulation of CXCL1 Expression and Viability in Human Breast Cancer Cell Lines Authors
by: Entkhab M. A. Alanisi, et al.
Published: (2025-07-01)

The diagnostic and prognostic value of CXCL13, CXCL10, and CXCL8 in patients with neurosyphilis
by: Hongjing Guan, et al.
Published: (2025-10-01)

Bioluminescent CXCL12 fusion protein for cellular studies of CXCR4 and CXCR7
by: Kathryn E. Luker, et al.
Published: (2009-07-01)

Assessment of CXCL13 plasma level in chronic lymphocytic leukemia and its relation to other prognostic markers
by: Omer Muhi Shareef, et al.
Published: (2024-05-01)

Age-related and postmenopausal breast cancer progression and treatment management: The significance of pro-inflammatory cytokines and CXC chemokines
by: Amin Ullah, et al.
Published: (2025-09-01)

Correlation between the expressions of CXCL8 and miR-150 in the skin lesions and the severity of psoriasis vulgaris
by: MA Hui, BI Xiaodong
Published: (2023-02-01)

Structural and Biological Characterizations of Novel High-Affinity Fluorescent Probes with Overlapped and Distinctive Binding Regions on CXCR4
by: Siyu Zhu, et al.
Published: (2019-08-01)

CXCR4-Targeted Radiopharmaceuticals for the Imaging and Therapy of Malignant Tumors
by: Jingjing Yu, et al.
Published: (2023-06-01)

HOXD1 regulates neural crest cells differentiation and polycerate development in sheep
by: Cheng Zhang, et al.
Published: (2025-04-01)

Silenced CXCL12 inhibits ox-LDL-induced foaming and apoptosis in mouse macrophage cell line RAW264.7
by: ZHUANG Hong, ZHANG Su-chuan, LIU Hui-di, XU Ya-ning, HUANG Lu, DAI Tian, JIANG Pin
Published: (2021-02-01)

Molecular Identification and Dual Functions of Two Different CXC Chemokines in Nile Tilapia (<i>Oreochromis niloticus</i>) against <i>Streptococcus agalactiae</i> and <i>Flavobacterium columnare</i>
by: Chatsirin Nakharuthai, et al.
Published: (2020-07-01)

Role of the Neutrophil in the Pathogenesis of Advanced Cancer and Impaired Responsiveness to Therapy
by: Bernardo L. Rapoport, et al.
Published: (2020-04-01)

Yuzhi Zhixue granules reduce endometrial fibrosis in rats with intrauterine adhesion
by: JIANG Yan-ling, DING Li, LI Fa-yu, JIE Shi-lei, ZHANG Yi-qiong
Published: (2022-08-01)

The Diagnostic and Predictive Value of Biomarkers for Pulmonary Fibrosis in Patients with Coronavirus Disease 2019
by: Jiapei Lv, et al.
Published: (2024-05-01)

Involvement of CXCL12/CXCR4 in CB2 receptor agonist-attenuated morphine tolerance in Walker 256 tumor-bearing rats with cancer pain
by: Dandan Liu, et al.
Published: (2024-12-01)

CXCL5 Modified Nanoparticle Surface Improves CXCR2<sup>+</sup> Cell Selective Internalization
by: Roberta Cagliani, et al.
Published: (2019-12-01)

miRNA-16-5p inhibits the apoptosis of high glucose-induced pancreatic β cells via targeting of CXCL10: potential biomarkers in type 1 diabetes mellitus
by: Xiaoyan Gao, et al.
Published: (2020-10-01)

The role of CXCR4 signaling in the migration of transplanted oligodendrocyte progenitors into the cerebral white matter
by: Ghazal Banisadr, et al.
Published: (2011-10-01)

Cxcl10 and Cxcr3 regulate self-renewal and differentiation of hematopoietic stem cells
by: Fangshu Liu, et al.
Published: (2024-08-01)

Allosteric modulation of the CXCR4:CXCL12 axis by targeting receptor nanoclustering via the TMV-TMVI domain
by: Eva M García-Cuesta, et al.
Published: (2024-09-01)

CXCL12-PLGA/Pluronic Nanoparticle Internalization Abrogates CXCR4-Mediated Cell Migration
by: Anissa Pisani, et al.
Published: (2020-11-01)